News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Oregon’s Biopharma Market Heats Up

https://www.biospace.com/article/oregon-s-biopharma-market-heats-up/

Published: Jun 05, 2019 By Mark Terry for BioSpace

The Oregon Bioscience Association recently released a new economic impact report, showing that the state’s biopharma and life science industry is continuing to grow at a significant clip. This is consistent with what is currently known about the American Northwest, which is also the BioSpace Bio Forest Hotbed. For example, a recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle as […]

June 17, 2019 |

$10.7 billion: More biotech firms, more life research, more jobs and higher industry wages in Oregon make an increasingly larger economic impact in Oregon

Released in 2019

Oregon’s bioscience and R&D industry continues its steady and significant growth.

With its dedication to improving the quality of life for people around the world, Oregon’s growing life science industry continues to shine. From new and better therapies for cancer and heart disease to improvements in wound care, drug delivery methods and use of artificial intelligence to advance precision medicine, Oregon companies are at the forefront of innovation. Considering Oregon’s renowned academic and research institutions along with recent significant […]

May 24, 2019 |

Oregon bioscience sector jobs and economic impact pack a punch

By  – Staff Reporter, Portland Business Journal
May 23, 2019, 3:32pm EDT 
https://www.bizjournals.com/portland/news/2019/05/23/oregon-bioscience-sector-jobs-and-economic-impact.html

Oregon is known more for its prowess in pinot noir than biosciences.

But bio’s economic footprint is about twice that of the wine industry, at $10.7 billion in 2017, according to a new study by Pinnacle Economics done for the Oregon Bioscience Association. Private bioscience concerns and public research institutions and hospitals directly generated $6.5 billion in economic […]

NEXT: NEW BIOTECH CAMPUS COMING TO INNOVATION QUADRANT

Following the 2018 announcement of the Eastside Innovation Hub at 808 S.E. Alder in Portland, the ‘NIR Center’ is ready to break ground in the heart of Portland’s IQ at Southeast 10th and Stark, featuring research, BioSafety Level 2 laboratory space and office/collaboration elements.

Portland, Ore.  – Metro Portland and Vancouver’s Summit Development Group purchased a majority of a southeast Portland block […]

April 29, 2019 |

SAN DIEGO BIO EXECUTIVE NAMED OREGON BIOSCIENCE ASSOCIATION’S NEW EXECUTIVE DIRECTOR

Bozinovic comes from Biocom Institute to join the local bio organization as it turns 30

(Portland, Ore.) –The Oregon Bioscience Association’s Board of Directors announced today the selection of its new Executive Director, Liisa Bozinovic, who will assume leadership of the trade/industry association on April 11, 2019.

Bozinovic comes to Oregon’s growing life science and medical device industry organization from […]

March 19, 2019 |

Oregon biotech company raises $5M to fuel growth from lab to clinic

By  – Staff Reporter, Portland Business Journal
Mar 7, 2019, 3:29pm EST

Eugene-based NemaMetrix, a biotech company that developed DNA testing equipment using nematode worms, has raised another $5 million, according to a filing with the U.S. Securities and Exchange Commission.

Oregon Venture Fund was the lead investor and Rogue Venture Partners also participated, said NemaMetrix CEO Matt Beaudet. This is the company’s fourth funding round, […]

March 11, 2019 |

Former Vice President Joe Biden on Monday said that under his new health care plan, people who like their insurance coverage won't be forced to give it up.Speaking at the AARP presidential forum [...]

Sen. Bernie Sanders (I-Vt.) on Monday attacked the pending closure of a Philadelphia hospital as an example of corporate greed taking priority over people's health.During a rally to save the 171- [...]

The FDA's March rejection of Sanofi and Lexicon Pharmaceuticals' Zynquista was just a preview of what would come for the SGLT class in Type 1 diabetes. The agency shot down AstraZeneca' [...]

WASHINGTON (AP) -- Medicare says it’s moving toward potentially covering acupuncture for chronic low back pain as an alternative to opioid painkillers that can become addictive. The agency announced i [...]

GE Healthcare has recalled two of its infant warmers--bedlike hospital devices designed to radiate heat and track the health of newborns--due to side panels and latches that may crack, break or open, [...]

GlaxoSmithKline laid out $5.1 billion last year for Tesaro and its key PARP inhibitor, Zejula, and with some new ovarian cancer data, it has another chance to prove the deal was worth it--and a shot a [...]

German pharma Boehringer Ingelheim is putting a few hundred million euros on the table to snap up Swiss cancer biotech Amal Therapeutics. [...]

Mr. Biden, who fought for the law as vice president, has criticized his progressive rivals who want to eliminate private health insurance. [...]